Frontier Pharma and Baystone Group acquire Serbian pharmaceutical company Zdravlje
12/01/2021
Britain’s Frontier Pharma and the Baystone investment group have acquired Serbian pharmaceuticals company Zdravlje Leskovac, its owner’s Serbia-based business said in a statement on Monday.
The statement did not specify the price paid for the takeover of the drugmaker, which is owned by Actavis, a subsidiary of Israeli company Teva.
Teva took control of Zdravlje Leskovac through its acquisition of Actavis in 2016.
“Our intention is to closely cooperate with Teva during this transition and to … in time develop the (Zdravlje Leskovac) company,” the statement said, citing Levent Selamoglu, Frontier Pharma’s chairman.